Risk of subclinical atherosclerosis across metabolic transition in individuals with or without fatty liver disease: a prospective cohort study
Metabolic dysfunction is a major determinant in the progression of fatty liver disease. It is pivotal to evaluate the metabolic status and subsequent transition in fatty liver population and to identify the ri...
Source: Nutrition and Metabolism - Category: Nutrition Authors: Zhuojun Xin, Jiaojiao Huang, Qiuyu Cao, Jialu Wang, Ruixin He, Tianzhichao Hou, Yi Ding, Jieli Lu, Tiange Wang, Zhiyun Zhao, Weiqing Wang, Guang Ning, Min Xu, Yufang Bi, Yu Xu and Mian Li Tags: Research Source Type: research
More News: Fatty Liver Disease (FLD) | Liver | Liver Disease | Nutrition | Study | Urology & Nephrology